rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Karl S. Dahlquist

Chief Legal Officer

Company insider

Files Form 4 as: Chief Legal Officer, AtriCure.

Every Form 4 they filed

In numbers

Trades disclosed
34
Buys
0
Sells
8
Bought
$0
Sold
$1.8M
Companies
1
Companies where not an officer
0
First trade
30 Jun 2021
Last trade
24 Aug 2026
Last filed
26 Aug 2026

Companies traded

Where they are an officer
ATRC AtriCureOfficer · Medical Devices · last 24 Aug 20260 buys · 8 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
10Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
24 Aug 2026filed 26 Aug 2026ATRC AtriCureMedical DevicesSEC FORM 4 Sold$458K9,370 at $48.89filing
24 Aug 2026filed 26 Aug 2026ATRC AtriCureMedical DevicesSEC FORM 4 Sold$458K9,370 at $48.89filing
30 Jun 2026filed 2 Jul 2026ATRC AtriCureMedical DevicesSEC FORM 4 Code A$15K636 at $23.78filing
30 Jun 2026filed 2 Jul 2026ATRC AtriCureMedical DevicesSEC FORM 4 Code A$15K636 at $23.78filing
1 Mar 2026filed 3 Mar 2026ATRC AtriCureMedical DevicesSEC FORM 4 Code A—27,991 at $0.00filing
1 Mar 2026filed 3 Mar 2026ATRC AtriCureMedical DevicesSEC FORM 4 Code A—15,198 at $0.00filing
1 Mar 2026filed 3 Mar 2026ATRC AtriCureMedical DevicesSEC FORM 4 Code F$490K15,687 at $31.26filing
1 Mar 2026filed 3 Mar 2026ATRC AtriCureMedical DevicesSEC FORM 4 Code A—27,991 at $0.00filing
1 Mar 2026filed 3 Mar 2026ATRC AtriCureMedical DevicesSEC FORM 4 Code A—15,198 at $0.00filing
1 Mar 2026filed 3 Mar 2026ATRC AtriCureMedical DevicesSEC FORM 4 Code F$490K15,687 at $31.26filing
30 Jun 2025filed 2 Jul 2025ATRC AtriCureMedical DevicesSEC FORM 4 Code A$21K822 at $25.84filing
1 Mar 2025filed 4 Mar 2025ATRC AtriCureMedical DevicesSEC FORM 4 Code A—19,359 at $0.00filing
1 Mar 2025filed 4 Mar 2025ATRC AtriCureMedical DevicesSEC FORM 4 Code A—6,579 at $0.00filing
1 Mar 2025filed 4 Mar 2025ATRC AtriCureMedical DevicesSEC FORM 4 Code F$382K9,870 at $38.74filing
28 Jun 2024filed 2 Jul 2024ATRC AtriCureMedical DevicesSEC FORM 4 Code A$14K707 at $19.35filing
18 Mar 2024filed 20 Mar 2024ATRC AtriCureMedical DevicesSEC FORM 4 Sold$61K1,885 at $32.16filing
5 Mar 2024filed 7 Mar 2024ATRC AtriCureMedical DevicesSEC FORM 4 Sold$308K8,231 at $37.36filing
1 Mar 2024filed 5 Mar 2024ATRC AtriCureMedical DevicesSEC FORM 4 Code A—22,050 at $0.00filing
1 Mar 2024filed 5 Mar 2024ATRC AtriCureMedical DevicesSEC FORM 4 Code A—8,231 at $0.00filing
1 Nov 2023filed 3 Nov 2023ATRC AtriCureMedical DevicesSEC FORM 4 Sold$43K1,248 at $34.43filing

News

Analyzing AxoGen (NASDAQ:AXGN) & AtriCure (NASDAQ:ATRC)ATRC · tickerreport.com · 18 Oct 2026

0 headlines in the last 90 days name Karl S. Dahlquist; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.

Sectors

Health Care8

Buys in green, sells in red, by the company’s sector.

Related people

Salvatore PriviteraChief Technical Officer · Chief Technical Officer at AtriCure, filing Form 4 there in the last year
Regina E. GrovesDirector · Director at AtriCure, filing Form 4 there in the last year
Karen PrangeDirector · Director at AtriCure, filing Form 4 there in the last year
Maggie YuenDirector · Director at AtriCure, filing Form 4 there in the last year
Michael H. CarrelDirector · President, CEO, & Director at AtriCure, filing Form 4 there in the last year
Gilbert Ray Cisneros, Jr.Representative, CA-31 · Also traded ATRC in the last 90 days
Justin J. NozneskyChief Mktg & Strategy Officer · Also traded ATRC in the last 90 days
Sven WehrweinDirector · Also traded ATRC in the last 90 days